Two Trump administration nominees with long track records of challenging the medical and public health establishments have ...
The reauthorization of OMUFA, the over-the-counter monograph drug user fee program, could serve as a platform for addressing issues like drug shortages and FDA policy changes. Drug pricing and ...
On January 7, 2025, the US Food and Drug Administration (FDA) issued two parallel guidance documents for the Section 503A and Section 503B bulk ...
Received FDA orphan drug designation for the treatment of dermatomyositis in April 2017. Received FDA approval for the treatment of dermatomyositis in adults in July 2021. The mechanism of action ...
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi as shareholders, is pleased to announce it has successfully completed ...
Asian News International on MSN9d
India reaffirms commitment to global Pharmaceutical standards at the 15th IMWPUnion Minister of State for Health and Family Welfare Anupriya Patel delivered the keynote address at the 15th International Meeting of World Pharmacopoeias ...
Canada NewsWire MONTREAL, Feb. 13, 2025 MONTREAL, Feb. 13, 2025 /CNW/ - Novartis Canada is pleased to announce that Health Canada has granted a Notice of Compliance for Fabhalta® ...
As someone with on-the-ground experience with USAID programs in Africa and Eastern Europe, I am appalled by the ...
CNW/ - Pharmascience Canada is proud to announce the launch of Pr pms-RUPATADINE (rupatadine), a treatment that helps relieve nasal and non-nasal ...
Many people depicted in a supposedly "groundbreaking" book on psychedelics and religion are now speaking out against it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback